Search Results - "Pellicelli, A.M"

Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD by Vespasiani-Gentilucci, U, Dell’Unto, C, Vorini, F, Monache, M.D, Cecere, R, Francia, C, Cerini, F, Galati, G, Gallo, P, De Vincentis, A, Pellicelli, A.M, Baiocchini, A, Picardi, A

Get full text

Efficacy and Safety of Simeprevir plus Sofosbuvir plus Ribavirin Flat Dose in a Population of Naive and Experienced HCV Genotype 1 Cirrhotic Elderly Patients: A Real World Experience from CLEO Group by Pellicelli, A.M, Palitti, V.P, Vignally, P, Moretti, A, Tarquini, P, Scifo, G, Messina, V, Ascione, A, Izzi, A, D’Ambrosio, C, Villani, R, Fondacaro, L, Fontanella, L, Guarascio, P, Alessio, L, amico, E.D, Ettorre, G.M, Marignani, M, Begini, P, Cerasari, G, Barlattani, A, Armignacco, O, Barbarini, G

Get full text

P1312 SOFOSBUVIR AND DACLATASVIR FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: POTENT ANTIVIRAL ACTIVITY BUT LACK OF CLINICAL BENEFIT IF TREATMENT IS GIVEN TOO LATE by Pellicelli, A.M, Lionetti, R, Montalbano, M, Durand, C, Ferenci, P, D'Offizi, G, Knop, V, Telese, A, Lenci, I, Andreoli, A, Zeuzem, S, Angelico, M

Get full text

Impact of different Sofosbuvir-based direct acting antiviral (DAA) regimen in elderly cirrhotic patients: A real world experience from CLEO Group by Pellicelli, A.M, Pace Palitti, V, Vignally, P, Moretti, A, Tarquini, P, Scifo, G, Messina, V, Ascione, A, Izzi, A, D’Ambrosio, C, Villani, R, Fondacaro, L, Fontanella, L, Guarascio, P, Alessio, L, Miglioresi, L, D’amico, E, Ettorre, G.M, Marignani, M, Begini, P, Cerasari, G, Barlattani, A, Armignacco, O, Barbarini, G

Get full text

484 IMPACT OF LIVER FIBROSIS IN DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS TREATED WITH ANTIVIRAL THERAPY: LONG TERM FOLLOW UP STUDY by Pellicelli, A.M, Vignally, P, Romano, M, Miglioresi, L, Mazzoni, E, Mecenate, F, Bonaventura, M.E, Villani, R, D'ambrosio, C, Fondacaro, L, Guarascio, P, Cerasari, G, Telesca, C, Andreoli, A, Barbarini, G

Get full text

Long term NUC treatment in hepatitis B virus HBeAg negative genotype D patients and risk for hepatocellular carcinoma: Evidence from the CLEO cohort study by Pellicelli, A.M, Vignally, P, Barbarini, G, Messina, V, Izzi, A, Mazzoni, E, Romano, M, Mecenate, F, Barlattani, A, Picardi, A, Vespasiani Gentilucci, U, D’ambrosio, C, Fondacaro, L, Miglioresi, L, Telesca, C, Cerasari, G, Guarascio, P, Andreoli, A, Stroffolini, T, Furlan, C, Gulminetti, R, Bonaventura, M.E, Bacca, D

Get full text

180 CLINICAL AND GENETIC FACTORS ASSOCIATED TO DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS WITHOUT HEPATOCELLULAR CARCINOMA by Pellicelli, A.M, D'Ambrosio, C, Barbaro, G, Villani, R, Guarascio, P, Fondacaro, L, Cortese, A, Atzori, M, Regine, G, Adami, L, Santoro, R, Ettorre, G.M, Andreoli, A

Get full text

186 PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS: SAFETY AND EFFICACY OF LOW DOSAGE OF ENOXAPARIN by Pellicelli, A.M, Guarascio, P, D'Ambrosio, C, Lusi, A.E, Villani, R, Fondacaro, L, Cerasari, G, Liotta, G, Vennarecci, G, Santoro, R, Ettorre, G.M, Andreoli, A

Get full text

826 ANTIVIRAL TREATMENT OF HCV CARRIERS WITH NORMAL ALT by Puoti, C, Pellicelli, A.M, Romano, M, Guarisco, R, Mecenate, F, Barbarini, G, Mazzoni, E, Barlattani, A, Picardi, A, Paffetti, A, Nosotti, L, Bonaventura, M.E, Villani, R, Bellis, L, Nicodemo, S, Spilabotti, L, Soccorsi, F

Get full text

OC3.10.3 ANTIVIRAL TREATMENT OF HCV CARRIERS WITH NORMAL ALT by Puoti, C, Pellicelli, A.M, Romano, M, Mecenate, F, Barbarini, G, Mazzoni, E, Barlattani, A, Picardi, A, Nosotti, L, Paffetti, A, Bonaventura, M.E, Villani, R, Guarisco, R, Bellis, L, Nicodemo, S, Spilabotti, L, Soccorsi, F

Get full text

Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib by Antonelli, G., Gigante, E., Iavarone, M., Begini, P., Biondetti, P., Pellicelli, A.M., Sangiovanni, A., Lampertico, P., Marignani, M.

Get full text

THU-178 - Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib by Antonelli, G., Gigante, E., Iavarone, M., Begini, P., Biondetti, P., Pellicelli, A.M., Sangiovanni, A., Lampertico, P., Marignani, M.

Get full text

Liver Transplant in Patient with Breast Cancer Liver Metastasis and Hepatic Failure by Giannelli, V., Meniconi, R., Guglielmo, N., Colasanti, M., D'Ambrosio, C., Cianni, R., Cortesi, E., Levi Sandri, G.B., Pellicelli, A.M., Ettorre, G.M.

Get full text

[170] PREVALENCE OF HYPERDYNAMIC CIRCULATION AND PORTOPULMONARY HYPERTENSION IN PATIENTS UNDERGOING LIVER TRANSPLANT EVALUATION by Pellicelli, A.M, Villani, R, Struglia, C, Nauri, L, D'Ambrosio, C, Fondacaro, L, Guarascio, P, Barbara, G, Paffetti, A, Romano, M, Barlattani, A, Mecenate, F, Mazzoni, E, Barbarini, G, Soccorsi, F

Get full text

THU-345 - Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD by Vespasiani-Gentilucci, U., Dell’Unto, C., Vorini, F., Monache, M.D., Cecere, R., Francia, C., Cerini, F., Galati, G., Gallo, P., De Vincentis, A., Pellicelli, A.M., Baiocchini, A., Picardi, A.

Get full text

Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib by Antonelli, G., Gigante, E., Iavarone, M., Begini, P., Sangiovanni, A., Iannicelli, E., Biondetti, P., Pellicelli, A.M., Miglioresi, L., Marchetti, P., Lampertico, P., Marignani, M.

Get full text

Mixed cryoglobulinemia patients with persisting symptoms after SVR are characterized by B-cell clonality markers by Lorini, S., Gragnani, L., Santarlasci, V., Monti, M., Basile, U., Petraccia, L., Madia, F., Marri, S., Martini, L., Carradori, E., Xheka, A., Caini, P., Pellicelli, A.M., Cosmi, L., Annunziato, F., Zignego, A.L.

Get full text

Non-invasive B-cell clonality markers may help in the rational approach to HCV SVR cryoglobulinemic patients with persisting manifestations by Lorini, S., Gragnani, L., Santarlasci, V., Monti, M., Basile, U., Petraccia, L., Madia, F., Marri, S., Martini, L., Carradori, E., Xheka, A., Caini, P., Pellicelli, A.M., Cosmi, L., Annunziato, F., Zignego, A.L.

Get full text

Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis by Masetti, C., Lionetti, R., Lupo, M., Siciliano, M., Giannelli, V., Ponziani, F.R., Teti, E., Dell’Unto, C., Francioso, S., Brega, A., Montalbano, M., Visco-Comandini, U., Taibi, C., Galati, G., Gentilucci, U. Vespasiani, Picardi, A., Andreoni, M., Pompili, M., Pellicelli, A.M., D’Offizi, G., Gasbarrini, A., De Santis, A., Angelico, M.

Get full text

THU-002 - Efficacy and Safety of Simeprevir plus Sofosbuvir plus Ribavirin Flat Dose in a Population of Naive and Experienced HCV Genotype 1 Cirrhotic Elderly Patients: A Real World Experience from CLEO Group by Pellicelli, A.M., Palitti, V.P., Vignally, P., Moretti, A., Tarquini, P., Scifo, G., Messina, V., Ascione, A., Izzi, A., D’Ambrosio, C., Villani, R., Fondacaro, L., Fontanella, L., Guarascio, P., Alessio, L., amico, E.D, Ettorre, G.M., Marignani, M., Begini, P., Cerasari, G., Barlattani, A., Armignacco, O., Barbarini, G.

Get full text